N-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide for Identifying Coronary Artery Disease and Left Ventricular Hypertrophy in Ambulatory Chronic Kidney Disease Patients

This publication has 23 references indexed in Scilit:

• Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure
  Heart, 2005
• Cardiovascular Mortality Risk in Chronic Kidney Disease
  JAMA, 2005
• The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study
  The American Journal of Cardiology, 2005
• Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension
  International Journal of Cardiology, 2004
• Diagnostic Accuracy of Cystatin C as a Marker of Kidney Disease in Patients with Multiple Myeloma: Calculated Glomerular Filtration Rate Formulas Are Equally Useful
  Clinical Chemistry, 2004
• N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris
  American Heart Journal, 2004
• Diagnostic and prognostic value of plasma brain natriuretic peptide in non—dialysis-dependent CRF
  American Journal of Kidney Diseases, 2004
• Evaluation of B-type natriuretic peptide for risk assessment in unstable Angina/Non–ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18
  Journal of the American College of Cardiology, 2003
• N-Terminal Pro-Brain Natriuretic Peptide After Myocardial Infarction
  Hypertension, 2002
• Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy
  The American Journal of Cardiology, 1986